Zeiler H J (34 results)

25 cm. XVIII, 491 S. Ill., graph. Darst. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Handbook of experimental pharmacology, Vol. 127. Sprache: Englisch.…

Condition: Good. 310 pp., paperback, ex library, else text clean & binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.…

Current Topics in Infectious Diseases and Clinical Microbiology Volume 2. IX. 299 S. Quart. mit Abbildungen. ISBN: 3528079797. Vieweg. Braunschweig. 1989. Mit Gebrauchsspuren/Used condition. Broschur/Softcover. Sprache: englisch/english.

Condition: New.

Condition: New.

Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: New.

PF. Condition: New.

Condition: New. In English.

Condition: New. In English.

Gebunden. Condition: New.

Condition: New. pp. xiv + 78.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - At a symposium in Wuppertal held on 26 September 1995, Dr. Karl-Georg Metzger was honored, on the occasion of his retirement, for his scientific contributions and involvement in antibacterial drug research and develop ment within Bayer AG. In 1963 Dr. Metzger was the first 'molecular micro biologist' to join Bayer in the field of antibacterial research. Karl-Georg Metzger studied physics and biology at the University of Mainz from 1950 to 1953 and continued his scientific education, with a grant from the Deutsche Forschungsgemeinschaft, in Frankfurt on Main (1953-1956). From 1956 to 1958, under Professor Kaplan, he worked on his DNA following treatment of PhD, studying on 'Energy conduction along bacteria with UV light and X-rays and the formation of mutations'. He was awarded his PhD in 1959. From 1958 to 1963 he was research assistant in ra diobiology development at the Institute of Genetics in Cologne. During the following years he became fascinated by the emerging fields of molecular biology and gene technology. He worked together with the molecular gen eticists W. Harms and M. Delbriick, who built up one of the most renowned institutes in the world, in Cologne. ''An incredibly interesting time:' Dr. Metzger remembers, in which he got to know a whole series of Nobel prize winners from Niels Bohr to Watson and Crick and Joshua Lederberg, the first to recombine genotypes of bacteria.…

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical practice. The modification produced in the quinolone nucleus by introducing a fluorine at the 6-position led to the discovery of the newer fluoroquinolones with enhanced antibacterial activities as compared to nalidixic acid. By now a great deal of preclinical and clinical experience has been obtained with these agents. The intense interest in this class of antibacterial agents by chemists, micro biologists, toxicologists, pharmacologists, clinical pharmacologists, and clini cians in various disciplines encouraged us to summarize the information on the history, chemistry, mode of action and in vitro properties, kinetics and efficacy in animals, mechanisms of resistance, toxicity, clinical pharmacology, clinical experience, and future prospects in one volume of the Handbook of Experimental Pharmacology. As this series deals predominantly with 'experimental' characteristics of drugs, our volume is dedicated specifically to quinolones and emphasizes principally their preclinical and clinical phar macological characteristics, despite the existence of several summaries on quinolones. The chemistry of the quinolones is described in detail. The chapter on the mode of action of quinolones reports the conclusive evidence that gyrase is the intracellular target of the quinolones; however, another enzyme, topoisomerase IV, may also be a target for quinolones, and the exact mechanisms by which quinolones act bactericidally are far from being understood.…

Condition: New. pp. 512.

Paperback. Condition: Brand New. 1st edition. 92 pages. 9.50x6.25x0.25 inches. In Stock.

Taschenbuch. Condition: Neu. Quinolone Antibacterials | Jochen Kuhlmann (u. a.) | Taschenbuch | Handbook of Experimental Pharmacology | xviii | Englisch | 2012 | Springer | EAN 9783642803666 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Paperback. Condition: Brand New. reprint edition. 491 pages. 9.00x6.25x1.25 inches. In Stock.

Condition: As New. Unread book in perfect condition.

Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: As New. Unread book in perfect condition.

Hardcover. Condition: gut. 1998. Quinolone Antibacterials (Handbook of Experimental Pharmacology. Continuation of Handbuch der experimentellen Pharmakologie, Vol. 127) In deutscher Sprache. pages.

Gebundene Ausgabe. Condition: Sehr gut. Gebraucht - Sehr gut - ungelesen,als Mängelexemplar gekennzeichnet, mit leichten Mängeln an Schnitt oder Einband durch Lager- oder Transportschaden -Beiträge aus dem US-amerikanischen, dem englischen, dem deutschen und dem österreichischen Rechtssystem geben einen fundierten Überblick über das jeweilige Fachgebiet in englischer bzwUS-amerikanischer Fachsprache. Den jeweiligen Facheinführungen folgen gebietsspezifische Glossare für die praktische Arbeit. Zielgruppe dieses Buches sind Rechtsanwälte, Wirtschaftsjuristen, Wirtschaftstreuhänder, Übersetzer und Studierende sowie all jene, die mit englischsprachigen Rechts- und Wirtschaftstexten zu tun haben. Dieses Buch kann sowohl als Nachschlagewerk als auch als Lehrbuch oder aber als Behelf zum Selbststudium verwendet werden.Band 1 umfasst die Rechtsgebiete Vertragsrecht, Gesellschaftsrecht, Handels- bzw Unternehmensrecht, deliktisches Schaden(s)ersatzrecht, Liegenschaftsrecht, Arbeitsrecht, Familienrecht, Erbrecht, Zivilprozessrecht und Schiedsgerichtsbarkeit. 752 pp. Deutsch.…

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -At a symposium in Wuppertal held on 26 September 1995, Dr. Karl-Georg Metzger was honored, on the occasion of his retirement, for his scientific contributions and involvement in antibacterial drug research and develop ment within Bayer AG. In 1963 Dr. Metzger was the first 'molecular micro biologist' to join Bayer in the field of antibacterial research. Karl-Georg Metzger studied physics and biology at the University of Mainz from 1950 to 1953 and continued his scientific education, with a grant from the Deutsche Forschungsgemeinschaft, in Frankfurt on Main (1953-1956). From 1956 to 1958, under Professor Kaplan, he worked on his DNA following treatment of PhD, studying on 'Energy conduction along bacteria with UV light and X-rays and the formation of mutations'. He was awarded his PhD in 1959. From 1958 to 1963 he was research assistant in ra diobiology development at the Institute of Genetics in Cologne. During the following years he became fascinated by the emerging fields of molecular biology and gene technology. He worked together with the molecular gen eticists W. Harms and M. Delbriick, who built up one of the most renowned institutes in the world, in Cologne. ''An incredibly interesting time:' Dr. Metzger remembers, in which he got to know a whole series of Nobel prize winners from Niels Bohr to Watson and Crick and Joshua Lederberg, the first to recombine genotypes of bacteria. 96 pp. Englisch.…

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical practice. The modification produced in the quinolone nucleus by introducing a fluorine at the 6-position led to the discovery of the newer fluoroquinolones with enhanced antibacterial activities as compared to nalidixic acid. By now a great deal of preclinical and clinical experience has been obtained with these agents. The intense interest in this class of antibacterial agents by chemists, micro biologists, toxicologists, pharmacologists, clinical pharmacologists, and clini cians in various disciplines encouraged us to summarize the information on the history, chemistry, mode of action and in vitro properties, kinetics and efficacy in animals, mechanisms of resistance, toxicity, clinical pharmacology, clinical experience, and future prospects in one volume of the Handbook of Experimental Pharmacology. As this series deals predominantly with 'experimental' characteristics of drugs, our volume is dedicated specifically to quinolones and emphasizes principally their preclinical and clinical phar macological characteristics, despite the existence of several summaries on quinolones. The chemistry of the quinolones is described in detail. The chapter on the mode of action of quinolones reports the conclusive evidence that gyrase is the intracellular target of the quinolones; however, another enzyme, topoisomerase IV, may also be a target for quinolones, and the exact mechanisms by which quinolones act bactericidally are far from being understood. 512 pp. Englisch.…

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical practice. The modification produced in the quinolone nucleus by introducing a fluorine at the 6-position led to the dis.…

Condition: New. Print on Demand pp. xiv + 78 6 Illus.

Taschenbuch. Condition: Neu. Antibacterial Therapy: Achievements, Problems and Future Perspectives | W. -D. Busse (u. a.) | Taschenbuch | xiv | Englisch | 1997 | Springer-Verlag GmbH | EAN 9783540628965 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. …